Could your blood type predict kidney treatment success?

NCT ID NCT07757269

Completed Knowledge-focused Sponsor: Cairo University Source: ClinicalTrials.gov ↗

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This study asks whether a person's ABO/Rh blood type is linked to how well their diabetic kidney disease responds to standard treatment. Researchers will follow 161 adults with type 2 diabetes and kidney disease for one year, measuring kidney function and protein in the urine at the start and end. The goal is to see if certain blood types are associated with better or worse outcomes, which could one day help tailor treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Laboratory measurements of kidney function and blood markers (eGFR, ACR, HbA1c, lipids, electrolytes)
What this could lead to: If blood type is linked to treatment response, doctors might personalize kidney disease care based on a simple blood test.
What could go wrong: This is an observational study, so it can show associations but not prove cause and effect. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic kidney disease impaired renal function disease kidney disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KIDNEY DISEASE

Contacts and locations

Locations

Faculty of medicine

Cairo, KasrAlainy, 11562, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.